NCT05182970View on ClinicalTrials.gov

Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)

PHASE3RecruitingINTERVENTIONAL
Enrollment

5,160

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
PreDiabetesAcute Myocardial InfarctionNon ST Elevation Myocardial InfarctionST Elevation Myocardial Infarction
Interventions
DRUG

Metformin

Individualised target dose of 2000 mg daily depending on tolerability.

Trial Locations (1)

341 35

RECRUITING

Medicinkliniken, Ljungby Hospital, Ljungby

All Listed Sponsors
collaborator

Capio Sankt Görans Hospital

OTHER

collaborator

Uppsala University

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

lead

Karolinska Institutet

OTHER